Jan R. H. Hanauer

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles

U. Şahin, K. Boller, Stephanie Erbar, 2017, Scientific Reports.

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles

U. Şahin, K. Boller, Stephanie Erbar, 2017, Scientific Reports.

Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model

Steffen Prüfer, M. Mühlebach, B. Bodmer, 2018, Virology.

DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

A. Plückthun, K. Cichutek, K. Peng, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

A. Plückthun, K. Cichutek, C. Buchholz, 2016, Molecular therapy oncolytics.

High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency

U. Lauer, M. Mühlebach, J. R. Hanauer, 2019, Molecular therapy oncolytics.

A single amino acid substitution in the measles virus F₂ protein reciprocally modulates membrane fusion activity in pathogenic and oncolytic strains.

K. Cichutek, C. Buchholz, Steffen Prüfer, 2014, Virus research.